AISNMA urges govt to deploy auto disable syringes to limit HIV epidemic

In the backdrop of 46 people getting infected with HIV due to reuse of a single syringe, the association of domestic syringe and needle manufacturers has sought urgent introduction of Universal Infection Prevention (UIP) guidelines across the country


New Delhi: Saddened to hear about 46 people getting infected with HIV due to reuse of a single syringe, Mr Rajiv Nath, President, All India Syringes and Needles Manufacturers Association (AISNMA) feels this could be just a tip of an iceberg as the problem is spread across the country. If this menace is not stopped, India could be staring at an HIV-AIDS epidemic, Mr Nath said questioning National AIDS Control Organization (NACO)’s lax attitude towards injection safety and preventable measures in its strategy to fight HIV.

Mr Rajiv Nath said, ‘UP’s healthcare is fragile. It needs urgent HSS and introduction of UIP including the urgent deployment of auto-disable syringes and needle stick prevention IV Cannula to immediately limit epidemic from spreading.’

“Is injection safety in public healthcare a key element in NACO’s strategy to fight HIV as is done in Africa?”, Mr Nath asked. The answer obviously is no as it thinks spread of infection via public healthcare is not an issue and therefore India has no funding or monitoring policy dedicated to public healthcare system strengthening. Further, there is no tracking of infections or registry via public healthcare from reuse of syringes/needles or needle stick injuries.

“NACO is myopic in limiting problem of Syringe reuse to only drug users”, Mr Nath said. Every time such tragedies like current one in Unnao or earlier in Modasa in Gujarat happens, it causes discussions and publication of a Guideline book and then forgotten. Bad habits can’t be changed by education alone if culturally ingrained and therefore reliance has to be on technology. As a car alarm forces you to belt up so does auto-disable (AD) Syringes ensure- no possibility of Reuse.

Quoting WHO, Mr Nath said that “Every $ 1 spent on injection safety saves $ 14 in public healthcare. A recent Health Technology Assessment study released by DHR finds Reuse Prevention AD Syringes cost-effective at Rs 1.90. Why use disposables that get misused and reused to become a carrier of infection without universal precautions?” As in immunization, AD syringes can be used universally for all therapeutic injections.

In this context, it is important to ask, what is India’s Road Map to switch to auto-disable syringes as per WHO advisory to achieve this by 2020? Uganda and Tanzania banned imports and use of Std Disposable syringes to fight HIV and to disallow access to Quacks and Private sector to Disposable Syringes. Why it is not being done in India?, Mr Nath implored further.

“It is high time Govt. takes immediate cognizance of the serious issue and deploy auto-disable syringes to save India from threat of HIV / AIDS epidemic. It is must for India to enforce Injection safety on a priority basis” concluded Mr Nath.